Medicago and InterveXion Therapeutics Establish Alliance to Develop Antibody Therapeutics
09-Jun-2005 -
Medicago and InterveXion Therapeutics, announced the formation of multi-year product co-development collaboration. The two companies will use Medicago's Proficia(TM) Protein Technology for the production of monoclonal antibodies therapeutics designed to treat drug abuse.
InterveXion has received ...
addiction
antibodies
business development
+6